Medtech Insight’s MTI 100 comprises a set of industry league tables providing US dollar rankings of medtech companies according to their overall annual medical device and IVD revenues where appropriate, and product sector-specific revenues where possible.
The 2023 MTI 100 list reflects a below-average level of M&A activity. The threshold for inclusion rose to half a billion US dollars for the first time. Several new names – many of them China-based IVD and other medical device manufacturers – have entered the lower reaches of the Top 100.
Welcome to In Vivo
Create an account to read this article
Already a subscriber?